A-shares closed · 港股休市 Quotes 行情 · 25 Sep 17:19 CST
27 Sep 2026 · 15:54 CST Terminal Access 终端入口 →

Unverified Reports 未经核实报告

Market talk about listed companies, with each company's answer.
上市公司市场传闻及公司回应。

921 candidate claims 候选记录
Read This First 重要提示

These claims are unverified. Do not trade on this page. 以下传闻均未经核实,请勿据此交易。

Coverage 覆盖范围
Source 来源Last Run 最近运行Read 读取On Claims 在列Note 备注
SZSE Q&A Board 互动易27 Sep 2026 04:01559605
SSE Q&A Board 上证e互动27 Sep 2026 04:0114121
Jiuyan Gongshe 韭研公社27 Sep 2026 04:014282 logged but on no claim 已记录但未关联传闻
Clarification Filings 澄清公告27 Sep 2026 04:015250From the Disclosure Wire 来自披露日志 · 1 logged but on no claim 已记录但未关联传闻
Volatility Statements 股票交易异常波动公告27 Sep 2026 04:10—83
Tonghuashun Newswire 同花顺 7x2427 Sep 2026 04:1120022
Sina Finance Newswire 新浪财经 7x2427 Sep 2026 04:115003
The Standard27 Sep 2026 04:111,00010
Jiemian News 界面新闻27 Sep 2026 04:125448
cninfo_clarify27 Sep 2026 04:01—00 held
Substack27 Sep 2026 04:12—0230 held

Not read (robots.txt refuses our crawler by name): Maimai 脉脉 and Xueqiu 雪球. Refused by the site: Weibo 微博 (needs a signed-in account) and Zhihu 知乎 (needs a signed-in account). Reachable but not read: Reddit (needs a registered Reddit API app).

2 of 921 candidate claims 候选传闻 · highest impact first 按影响排序

Showing the claims that name Cansino Biologics 康希诺. 仅显示提及该公司的传闻。 Show every company 全部

Medium 中等 · 40 Unverified 未经核实 No Clear Answer 未明确表态
First posted 首见 21 Aug 2026 09:56
Logged 记录 19 Sep 2026 04:25
Impact 影响 40 · Other 其他 · Stock +20.0% on 21 Aug 2026 (5.3× its usual move) · Market value ¥202亿
Investor’s Question 投资者提问 · SSE Q&A Board 上证e互动 · 21 Aug 2026 09:56 · Source ↗

您好,请问贵司13价肺炎结合疫苗批签发,一批次25万剂,是否属实?

Why Logged 收录依据: A request to verify, with no rumour word

Company’s Answer 公司回复 · 21 Aug 2026 18:10

尊敬的投资人您好,中检院自2021年4月中旬起不再公布疫苗产品的批签发数量,公司会参考同行的信息公示处理方式执行。公司会根据相关产品的市场需求做好产销协同工作,争取更好的经营结果。谢谢!

No Clear Answer 未明确表态 No rule matched 无匹配规则
Corroboration 印证度
1 of 5 sources 信源 · 1 sighting on 1 venue
Seen On 来源
SSE Q&A Board 上证e互动
Related Stocks 相关标的
Clarification Filings on the Same Stock 窗口内澄清公告
22 Aug 2026 · 股票交易异常波动公告 · 0.6 days after the claim was first posted · No verdict
Medium 中等 · 40 Unverified 未经核实 No Clear Answer 未明确表态
First posted 首见 21 Aug 2026 09:55
Logged 记录 19 Sep 2026 04:25
Impact 影响 40 · Other 其他 · Stock +20.0% on 21 Aug 2026 (5.3× its usual move) · Market value ¥202亿
Investor’s Question 投资者提问 · SSE Q&A Board 上证e互动 · 21 Aug 2026 09:55 · Source ↗

请问,贵司自研的ISL-3C-LNP三组分递送系统已与阿斯利康、盖茨基金会等建立合作,推动胶质母细胞瘤GBM治疗性疫苗及mR­NA-HPV治疗性疫苗等相关管线开发,是否属实?

Why Logged 收录依据: A request to verify, with no rumour word

Company’s Answer 公司回复 · 21 Aug 2026 18:10

尊敬的投资人您好,对于mRNA治疗性疫苗产品,除了横纹肌肉瘤疫苗及胶质母细胞瘤疫苗,也在持续规划其他管线,后续请关注公司对于阶段性进展的相关信息披露,谢谢!

No Clear Answer 未明确表态 No rule matched 无匹配规则
Corroboration 印证度
1 of 5 sources 信源 · 1 sighting on 1 venue
Seen On 来源
SSE Q&A Board 上证e互动
Related Stocks 相关标的
Clarification Filings on the Same Stock 窗口内澄清公告
22 Aug 2026 · 股票交易异常波动公告 · 0.6 days after the claim was first posted · No verdict
First 首页 Previous 上一页 Page 1 of 1 · Claims 1 to 2 of 2 Next 下一页 Last 末页
Claims per Page 每页 25 50 100